US Bancorp
CARL icon

US Bancorp’s Carlsmed CARL Stock Holding History

US Bancorp’s Portfolio CARL Stock Details CARL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.23K Hold
600
– – ﹤0.01% 3593
2026
Q1 		$5.43K Buy
+600
New +$7.25K ﹤0.01% 3545

Other funds holding CARL

Jupiter Topco
Jupiter Topco New York $245B AUM
Parkman Healthcare Partners
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KC
KCM Capital Shawnee, Kansas $618M AUM
Pier Capital
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Palumbo Wealth Management
Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Schonfeld Strategic Advisors
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

US Bancorp's CARL Position: Q2 2026 in Review

US Bancorp held its Carlsmed (CARL) position steady in Q2 2026 at 600 shares worth $6.23K. The position accounts for ﹤0.01% of the portfolio, ranked #3593.

US Bancorp first reported a position in CARL in Q1 2026 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold CARL as of Q2 2026.

  • US Bancorp held 600 shares of Carlsmed worth $6.23K as of Q2 2026.
  • US Bancorp left its Carlsmed share count unchanged in Q2 2026.
  • Carlsmed made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3593 holding.
  • US Bancorp first reported a position in Carlsmed in Q1 2026 and has held it in 2 quarters since.
  • 74 funds tracked by Wall St. Rank held Carlsmed as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.